Posts tagged nanomaterial
Vireo Publishes "Characterization of a Human In Vitro Intestinal Model for the Hazard Assessment of Nanomaterials Used in Cancer Immunotherapy"

Vireo, and our co-authors at Baylor University, have published a study advancing the use of alternative testing strategies for nanomaterial safety assessments.

Read More
A Robust Cell-based Model Useful for Predicting Potential Adverse Effects on the Lung Following Nanomaterial Inhalation

Recent efforts are aiming to promote the use and adoption of Adverse Outcome Pathways (AOPs) to demonstrate the safety of advanced materials and technologies such as nanomaterials.

Read More
Vireo Advisors Coordinating OECD Workshop to Advance Use of Adverse Outcome Pathways (AOP) for Nanomaterial Risk Assessment

Vireo Advisors is collaborating with Health Canada and two European Horizon2020 projects to coordinate two back-to-back workshops at the OECD: “Advancing Adverse Outcome Pathway (NanoAOP) Development for Nanomaterial Risk Assessment and Categorization” (NanoAOP Workshop), to be held 11 September 2019, and a stakeholder workshop organized by the EU H2020 Project Physiologically Anchored Tools for Realistic nanOmateriaL hazard aSsessment (PATROLS ), to be held 12 September 2019.

Read More
USDA Forest Service and P3Nano Collaborative Projects on Cellulose Nanomaterials

During a review meeting at the USDA Forest Service Forest Products Laboratory (FPL) in Madison, Wisconsin, the USDA Forest Service and the US Endowment for Forestry and Communities discussed a public-private partnership named P3Nano examined projects in which they had co-invested in 2016 in an effort to fund cellulose nanomaterials research ($4 million total, $2 million from FS, $2 million from the partner).

Read More
EPA Released Updated Guidance for the TSCA Nano Rule   

The Toxic Substances Control Act (TSCA) Section 8(a) Information Gathering Rule on Nanomaterials in Commerce (EPA Nano Rule) took effect on August 14th (see our updates on this rule here).

Read More